Real-world use of ticagrelor versus clopidogrel in percutaneous coronary intervention-treated ST-elevation myocardial infarction patients : A single-center registry study
OBJECTIVES: The primary aim was to investigate the efficacy and safety of dual antiplatelet therapy (DAPT) using ticagrelor (T-DAPT) versus clopidogrel (C-DAPT) in a real-world ST-elevation myocardial infarction (STEMI) population
Bibliographische Detailangaben
| Veröffentlicht in: | Journal of the Saudi Heart Association. - 1999. - 31(2019), 4 vom: 01. Okt., Seite 151-160
|
|---|
| 1. Verfasser: |
Hee, Leia
(VerfasserIn) |
|---|
| Weitere Verfasser: |
Gibbs, Oliver J,
Assad, Joseph G,
Sharma, Lokesh D,
Hopkins, Andrew,
Juergens, Craig P,
Lo, Sidney,
Mussap, Christian J |
|---|
| Format: | Online-Aufsatz
|
|---|
| Sprache: | English |
|---|
| Veröffentlicht: |
2019
|
|---|
| Zugriff auf das übergeordnete Werk: | Journal of the Saudi Heart Association
|
|---|
| Schlagworte: | Journal Article
Bleeding Academic Research Consortium (BARC)
Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the American College of Cardiology/American Heart Association Guidelines (CRUSADE)
Dual antiplatelet therapy (DAPT)
Percutaneous coronary intervention (PCI)
ST-elevation myocardial infarction (STEMI) |
|---|